Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

NCT02964923 ·Status: UNKNOWN

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

NCT02248987 ·Status: COMPLETED

Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs

NCT01479413 ·Status: COMPLETED

A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

NCT01959659 ·Status: COMPLETED

Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia

NCT01587521 ·Status: COMPLETED

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

NCT01160679 ·Status: COMPLETED

Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia

NCT05498571 ·Status: UNKNOWN

Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia

NCT01222793 ·Status: COMPLETED

Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia

NCT01324167 ·Status: UNKNOWN

Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

NCT00330226 ·Status: UNKNOWN

Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia

NCT02614586 ·Status: TERMINATED ·Phase: PHASE1

Metformin Treatment on Cognitive Impairment of Schizophrenia

NCT05838573 ·Status: RECRUITING ·Phase: PHASE3

The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan

NCT01170689 ·Status: COMPLETED

Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome

NCT04518319 ·Status: SUSPENDED ·Phase: PHASE2

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

NCT05245539 ·Status: COMPLETED ·Phase: PHASE1

Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

NCT00222807 ·Status: COMPLETED

This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.

NCT07184710 ·Status: NOT_YET_RECRUITING

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

NCT03451734 ·Status: COMPLETED

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

NCT02205437 ·Status: UNKNOWN

Study of Pharmacotherapy of Psychotic Depression

NCT00056472 ·Status: COMPLETED ·Phase: PHASE3

Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication

NCT00698295 ·Status: UNKNOWN

Waist Circumference Measurements in Schizophrenic Patients

NCT01243034 ·Status: COMPLETED

Adverse Events and Genomics in Schizophrenia

NCT01966588 ·Status: UNKNOWN

Neuroendocrine and Metabolite Substrates in Schizophrenia

NCT02423096 ·Status: UNKNOWN

Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.

NCT00945503 ·Status: COMPLETED ·Phase: PHASE1